NewLimit

NewLimit Develops Anti-Aging Technology to Reverse the Aging Process and Extend Human Lifespan. The company uses epigenetic reprogramming therapy and single-cell sequencing to rejuvenate tissues throughout the body, enabling customers to fundamentally extend their healthy lifespan. NewLimit is developing epigenetic reprogramming drugs to address a wide range of unmet medical needs.